- BGI Genomics Announces Pricing of Initial Public Offering
- BGI Launches the Latest Desktop Sequencer BGISEQ-50
- International Science Community Welcomes China National GeneBank Opening
- BGI and Clearbridge BioMedics Partner to Develop China CTC Liquid Biopsy Market towards Precision Medicine
- The international Sc2.0 Project is on track to build the world’s first synthetic yeast genome
- Avian-specific conserved genomic elements play important regulatory roles in the macroevolution of avian-specific features
- The Evolution of Chronic Lymphocytic Leukemia Revealed
- BGI involved in publication of the first seahorse genome in Nature
- Leading Health Organizations in Canada and China Teaming up to Accelerate Precision Medicine
- World’s largest genomic organisation to collaborate with leading Queensland researchers
- Ranomics Partners with BGI to Classify Variants of Unknown Significance
- BGI and UW collaborate on precision medicine development
- Chinese innovation : BGI’s code for success
- Prof. Huanming Yang to Receive Membership from Royal Danish Academy of Sciences and Letters
- UW, Chinese genomics group forge new partnership to advance biomedical research
- Mapping more genomes will create a healthcare 'big data revolution'
Tel: +86-755-36307212Email: email@example.com
On February 10, 2014, Fast Company announced 2014 ranking of The World's 50 Most Innovative Companies and the Top 10 Most Innovative Companies in 10 critical areas. BGI has been ranked No. 37 in the top 50 and for the second time listed in the Top 10 in China, rising from last year’s fourth to 2nd in 2014. The ten companies in China are Xiaomi, BGI, China's luxury brands, Haier, Tencent, Geak, Phantom, Baidu, YY and CooTek.
BGI – For making DNA sequencing mass-market
By investing in more cutting-edge genome-sequencing hardware and training more analysts to make sense of reams of data output than any research institution or university in the world, BGI has turned itself into a go-to destination for global scientists seeking collaboration on ambitious projects to unlock the mysteries of plant, animal, and human DNA. The Shenzhen, China–based institute (it was founded in Beijing) is now the most prolific sequencer of human genomes, using technological advances to drive steep drops in the cost of sequencing complete genomes, from $3 billion in 2003 to mere thousands today. Its goal is to organize the world's biological information and make it useful and accessible to all--like a biological Google. Under its director, Dr. Jun Wang, its projects are wide-ranging, from decoding rice genomes for improving agriculture to parsing the biological roots of human intelligence. In March 2013, BGI turned its attention to the West, acquiring California-based Complete Genomics, a leading developer and manufacturer of genome-sequencing machines, for $118 million, giving it even more firepower.